Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03952546 · ClinicalTrials.gov registry record · NA
To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT03952546 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 211 participants.
The verdict
NCT03952546, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether the saline-coupled bipolar sealer compared to the unipolar electrocautery provides superior hemostasis in patients undergoing primary unilateral total knee arthroplasty. This will be a prospective, randomized, single-blinded, non-inferiority study in patients scheduled for a primary unilateral total knee arthroplasty (TKA) with Dr. Eugene Krauss or Dr. Ayal Segal. The restriction of this study to two surgeons will limit variations in the outcomes being measured due to differences in surgical technique.
Interventions
- DEVICE Saline-coupled Bipolar Sealer
- DEVICE Unipolar electrocautery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2021-06-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03952546
The ClinicalTrials.gov registry entry for NCT03952546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline-coupled Bipolar Sealer is the first listed.
NCT03952546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03952546 about?
NCT03952546 is a clinical study titled "To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty". The purpose of this study is to investigate whether the saline-coupled bipolar sealer compared to the unipolar electrocautery provides superior hemostasis in patients undergoing primary unilateral total knee arthroplasty. This will be a prospective, randomized, single-blinded, non-inferiority study ...
What is the current status of trial NCT03952546?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2019-05-07. Estimated completion is 2021-06-09.
What interventions are being tested in trial NCT03952546?
The interventions under investigation include: Saline-coupled Bipolar Sealer (DEVICE), Unipolar electrocautery (DEVICE).
Who is sponsoring clinical trial NCT03952546?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.